Better Therapeutics Investor Relations Material

Better Therapeutics Inc. is a digital therapeutics company focused on developing prescription digital therapies to treat cardiometabolic diseases, such as type 2 diabetes and hypertension. The company’s platform delivers cognitive-behavioral therapy (CBT) through a mobile application designed to modify behavioral habits that contribute to these conditions. By targeting the root causes of cardiometabolic diseases, Better Therapeutics aims to offer non-invasive, software-based treatment options that can be prescribed by healthcare providers. The company is focused on integrating its digital therapeutics into clinical care to improve patient outcomes. The company is headquartered in San Francisco, California, and its shares are listed on the NASDAQ.